Patent · US Expired

Defective CD4+T-cells that express active CD40-L

US6613320B1 · kind B1 · utility

0Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2000
Grant dateSep 2, 2003
Priority date—
Expiry dateApr 10, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

CD4+ cells obtained from individuals with defective CD40L gene and transfected with a vector containing CD40-L are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.